Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by wagyusteakon Dec 18, 2020 6:09pm
146 Views
Post# 32145465

RE:RE:RE:RE:RE:Consistent stronger volume

RE:RE:RE:RE:RE:Consistent stronger volume
House Positions for C:GUD from 20201218 to 20201218
House Bought $Val Ave Sold $Val Ave Net $Net
1 Anonymous 3,844,936 20,694,800 5.382 720,005 3,844,145 5.339 3,124,931 -16,850,655
80 National Bank 3,202,866 17,262,712 5.39 1,366,514 7,375,682 5.397 1,836,352 -9,887,030
53 Morgan Stanley 1,094,745 5,909,381 5.398 114,466 615,013 5.373 980,279 -5,294,368
13 Instinet 1,043,000 5,627,087 5.395 360,316 1,920,803 5.331 682,684 -3,706,284
39 Merrill Lynch 292,100 1,572,881 5.385 42,184 225,585 5.348 249,916 -1,347,296
33 Canaccord 131,649 701,149 5.326 28,951 155,690 5.378 102,698 -545,459
72 Credit Suisse 93,400 504,509 5.402 2,502 13,537 5.41 90,898 -490,972
19 Desjardins 12,885 67,836 5.265 4,060 21,787 5.366 8,825 -46,049
68 Leede 4,500 23,949 5.322 1,200 6,438 5.365 3,300 -17,511
90 Barclays 1,455 7,857 5.40 0   1,455 -7,857
5 Penson 44,199 235,510 5.328 43,669 231,417 5.299 530 -4,093
57 Interactive 500 2,660 5.32 0   500 -2,660
88 Credential 380 1,987 5.229 0   380 -1,987
35 Friedberg 600 3,138 5.23 300 1,620 5.40 300 -1,518
212 Virtu 821 4,428 5.393 612 3,269 5.342 209 -1,159
14 ITG 0   500 2,622 5.244 -500 2,622
15 UBS 0   2,170 11,718 5.40 -2,170 11,718
124 Questrade 225 1,210 5.378 4,000 21,121 5.28 -3,775 19,911
76 Industrial Alliance 0   4,400 23,312 5.298 -4,400 23,312
77 Peters 0   7,000 36,890 5.27 -7,000 36,890
79 CIBC 278,265 1,485,917 5.34 359,397 1,919,694 5.341 -81,132 433,777
65 Goldman 93,160 503,064 5.40 275,082 1,454,270 5.287 -181,922 951,206
7 TD Sec 212,431 1,140,745 5.37 467,095 2,508,332 5.37 -254,664 1,367,587
2 RBC 162,030 870,036 5.37 460,225 2,478,205 5.385 -298,195 1,608,169
222 JP Morgan 0   361,818 1,953,817 5.40 -361,818 1,953,817
89 Raymond James 1,000 5,380 5.38 570,000 3,073,189 5.392 -569,000 3,067,809
85 Scotia 34,560 183,127 5.299 608,891 3,287,680 5.399 -574,331 3,104,553
9 BMO Nesbitt 172,902 928,998 5.373 4,917,252 26,552,524 5.40 -4,744,350 25,623,526
TOTAL 10,722,609 57,738,361 5.385 10,722,609 57,738,360 5.385 0 -1

<< Previous
Bullboard Posts
Next >>